Esteban Masuda
2018
In 2018, Esteban Masuda earned a total compensation of $1.3M as Executive Vice President, Research at Rigel Pharmaceuticals, a 104% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $227,552 |
---|---|
Option Awards | $719,270 |
Salary | $350,080 |
Other | $3,336 |
Total | $1,300,238 |
Masuda received $719.3K in option awards, accounting for 55% of the total pay in 2018.
Masuda also received $227.6K in non-equity incentive plan, $350.1K in salary and $3.3K in other compensation.
Rankings
In 2018, Esteban Masuda's compensation ranked 7,883rd out of 14,244 executives tracked by ExecPay. In other words, Masuda earned more than 44.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,883 | 45th |
Manufacturing | 3,080 | 47th |
Chemicals And Allied Products | 1,153 | 46th |
Drugs | 970 | 46th |
Pharmaceutical Preparations | 753 | 46th |
Masuda's colleagues
We found five more compensation records of executives who worked with Esteban Masuda at Rigel Pharmaceuticals in 2018.
2018
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2018
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2018
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
2018
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2018
Dean Schorno
Rigel Pharmaceuticals